Pharos Capital Launches Verdi Oncology through Horizon Oncology Acquisition

We represented Pharos Capital Group in its acquisition of Horizon Oncology. The acquisition marks the launch of Verdi Oncology, Inc., an oncology practice and clinical research management company. Financial terms of the transaction were not publicly disclosed.

Horizon Oncology offers a wide range of comprehensive cancer services to patients, including advanced technological options, premier clinical expertise and cutting edge clinical trials opportunities, with a focus on early phase trials.

Pharos Capital Group is an SEC Registered Investment Advisor. As of March 2018, Pharos has invested in 51 companies and currently has over $690 million of private equity assets under management.

You Also May Be Interested In:

  • Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019.¬†¬†Serco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.

    We represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation's Naval Systems Business...
    Client Type: Private Company
  • Represented C-III Capital Partners in its sale of California-based tech company Real Capital Markets (RCM) to LightBox

    We represented C-III Capital Partners, a fully-diversified asset management and commercial real estate services company, in its sale of California-based...
    Client Type: Private Company
  • We have successfully defended our clients against roughly $26 million in ACA employer mandate penalties, which relate to the ACA mandate that requires employers with 50 or more full-time employees to offer minimum essential health coverage to those employees (and their children up to age 26) or be subject to penalties.

    We have successfully defended our clients against roughly $26 million in ACA employer mandate penalties, which relate to the ACA...
    Client Type: Private Company